OPKO Health, Inc. Temporary Equity, Liquidation Preference
OPKO Health, Inc. (OPK) had Temporary Equity, Liquidation Preference of $0 as of 2013-12-31, per its 10-K filed 2014-03-03.
Discontinued › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2014-03-03
- 2013-12-31: Temporary Equity, Liquidation Preference $0.00.
- 2013-09-30: Temporary Equity, Liquidation Preference $0.00.
- 2013-06-30: Temporary Equity, Liquidation Preference $0.00.
- 2013-03-31: Temporary Equity, Liquidation Preference $0.00.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-03 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-12 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 |
| 2012-12-31 | $30.59M 10-K · filed 2014-03-03 |
| 2012-09-30 | $30.04M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $29.48M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $28.91M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $28.36M 10-K · filed 2013-03-18 |
| 2011-09-30 | $34.81M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $34.21M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $33.01M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |